Clinical Trials in Pittsburgh

Showing 11961-11980 of 21,047 trials

A Long-Term Study of Rovalpituzumab Tesirine

NCT03543358

The purpose of this long-term, extension study is to provide ongoing safety and efficacy follow-up of subjects who participated in a rovalpituzumab tesirine study that has completed the primary analysis and that is closing.

Cancer

AbbVie3 participantsStarted Sep 2018

Tucson, Arizona, United States • Duarte, California, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

NCT01578499

The purpose of this study is to determine objective response rate (ORR), lasting at least 4 months (ORR4), with brentuximab vedotin in participants with cluster of differentiation antigen 30 positive (CD30+) cutaneous T-cell lymphoma \[mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma (pcALCL) \]compared to that achieved with therapy in the control arm.

Primary Cutaneous Anaplastic Large Cell LymphomaMycosis FungoidesCutaneous T-Cell Lymphoma

Millennium Pharmaceuticals, Inc.131 participantsStarted Jun 2012

Los Angeles, California, United States • Palo Alto, California, United States • Chicago, Illinois, United States +38 more locations

A Long-Term Study of Rovalpituzumab Tesirine

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

Find Trials by Condition in Pittsburgh

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

A Study of CLR325 in Chronic Stable Heart Failure Patients.

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients

Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Topical CP-690,550 For Chronic Plaque Psoriasis

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

The Effect of Sorafenib on Portal Pressure

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

Gliogene: Brain Tumor Linkage Study

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma